Navigation Links
BioVex Closes Second Round of Series E Financing
Date:11/15/2007

Second and Final Close Completes $35 Million Financing

WOBURN, Mass., Nov. 15 /PRNewswire/ -- BioVex Inc, a clinical stage company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today it had completed its Series E financing, concurrent with the completion of a venture debt transaction, raising a total of $35m of funds.

BioVex intends to use the capital to complete its preparations for, and to commence, a Phase III study with its lead product OncoVex GM-CSF for the treatment of melanoma as well as to complete studies in head and neck cancer and pancreatic cancer. The financing will also fund the Company's second program, ImmunoVEX HSV2, a vaccine for genital herpes, through to Phase II.

The Series E placement was led by Triathlon Medical Ventures who were joined by new investors New Science Ventures and Harris and Harris Group, Inc., as well as existing investors. The venture debt facility was provided by Oxford Finance Corporation and Silicon Valley Bank.

About BioVex

BioVex is a privately held biotechnology Company based in Woburn. MA. The Company is developing a new class of potent biologics for the treatment of cancer and prevention of infectious disease.

BioVex's lead cancer program, OncoVEX GM-CSF, is an oncolytic virus that selectively destroys tumor cells accompanied by the induction of a systemic immune response. OncoVEX GM-CSF is currently completing a Phase II clinical trial for melanoma and Phase I/II clinical trials for head & neck cancer and pancreatic cancer. Preliminary data from these studies has been very encouraging demonstrating OncoVEX GM-CSF has the potential to treat both local and metastatic disease. The Company is currently preparing for an initial registration study in melanoma where multiple responses have been demonstrated in an ongoing Phase II trial testing OncoVEX GM-CSF as stand alone therapy in patients with un-resectab
'/>"/>

SOURCE BioVex Inc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
3. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
4. Genmab Discloses Target and Development Plans for HuMax-Inflam
5. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
6. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
7. Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund
8. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
9. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...dor to Speak at Economic Club of Canada , ...25, 2009 -- Ambassador to Speak at Economic Club o...sador for International Investment, and Chairman a...iography of David Appia go to www.investinfrance....o meet with press to discuss recent pro-business i...
(Date:11/25/2009).../PRNewswire/ - Cytochroma today announced the appo...ors. Dr. Moldt will replace Mr. Ulrik Spork as the...he number of Board members remains unchanged at si...eter Moldt to the board and look forward to benefi...a continues to make progress in becoming a leading...
(Date:11/25/2009)...25 Reportlinker.com announces that...catalogue: ,, Brazil Bioethanol Market Analysi...inker.com/p0165503/Brazil-Bioethanol-Market-Analys...anol Market Analysis and Forecasts to 2013 ,, ...is and forecasts of the global bioethanol market a...
(Date:11/24/2009)...German . , Whether it,s CD packaging, contai...quency Identification) are increasingly finding th...to label objects or goods and identify them automa...r can read and process the data contained in the l...roduction conditions of up to 100 degrees Celsius....
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Intelligence inside metal components 2
...4, 2007 at 5:00 a.m. (Pacific) / 8:00 a.m. (Eas...China, Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- 3S...iotechnology company focused on,researching, devel...al,products, today announced that it will release ...ended September 30, 2007 after the US market close...
...), a global healthcare company, today released its...7 to September 30, 2007. -- Novo Nordisk increase... Danish kroner due to a significant negative curr...increased by 37% (31% in Danish kroner). -- Sa... kroner). -- Sales of Norditropin(R) increased...
...tar,Biopharmaceuticals AG., today announced first ...labelled Phase IIa pilot study in 14 patients with...g 70 mg of Bimosiamose,twice a day. The study was ...Berlin, Prof. Witt and the Respiratory Institute W...ing the recent European Respiratory,Society Meetin...
Other Biology Technology:3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007 2Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin 2Revotar Reports First Positive Clinical Results From Phase IIa Study in COPD 2
(Date:11/25/2009)...st as vital to your health as what you eat, found ...tudies. Their experiments in mice revealed that th... the liverthe body,s metabolic clearinghouseis mos...s circadian clock as conventional wisdom had it. ...large number of genes completely independent of th...
(Date:11/24/2009)...in that may help gut bacteria bind to the gastroin...otic producers to identify strains that are likely...eed to interact with cells lining the gut to have ...s in the gut they are more likely to stick around ...alie Juge from the Institute of Food Research. IF...
(Date:11/24/2009)...4, 2009) -- The Wildlife Conservation Society (WCS... remaining population of Siberian tigers has likel... poaching and habitat loss. , WCS sa...f what needs to be done to protect remaining popul... The report was released by the Siberian Tiger Mo...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2Twitter and health care can a tweet a day keep the doctor away 3F 55147 1Twitter and health care can a tweet a day keep the doctor away 3F 55147 2Lower cost solar cells to be printed like newspaper painted on rooftops 9681 1Lower cost solar cells to be printed like newspaper painted on rooftops 9681 2Marital Separation May Hurt Cancer Survival 55143 1Marital Separation May Hurt Cancer Survival 55143 2
...e nitrogen cycle plays a major role in seagrass fi...gen dynamics of seagrasses in Indonesia. He discov...als and microorganisms results in an efficient nit...tly the nitrogen lost from seagrasses is still ret...with important functions for coastal stability and...
...w research in the Society of Chemical Industrys Jo... that oregano oil works as well as synthetic insec...Rhizoppertha dominica, found in stored cereals. , ...ic versions but it has none of the associated side...ent. , Growing resistance to synthetic insectici...
...ndon, ON According to the World Health Organizati...ople around the world and population growth, urban...r use are making the problem worse. By examining ...ion, a researcher at The University of Western Ont... , Western geography professor Katrina Moser stud...
Other Biology News:Nitrogen retained through loss 2Researcher strives for watershed moment 2
T4 DNA Ligase; (1 x 103 U/ml) or (5 x 103 U/ml) supplied with 10x ligation buffer that includes ATP from Roche Applied Science
...a nonspecific endonuclease that degrades double-an...by hydrolyzing phosphodiester linkages, producing ...a 3'-hydroxyl group. Ambion's RNase-free DNase I i...ed to degrade DNA in the presence of RNA when the ...
Rabbit Anti-Neuromedin U Receptor 1 Polyclonal Antibody, Unconjugated from Novus Biologicals
... shortages in your laboratory or fellow researcher...nted distractions, problems and delays. • &...eavour! Bring us your idea and let us build it up ...001 quality assurance in design, development, prod...
Biology Products: